First COVID-19 oral treatments approved

By Andrew Brown
Updated January 20 2022 - 8:41am, first published 8:35am
The federal government has secured 500,000 courses of Paxlovid and 300,000 courses of Lagevrio.
The federal government has secured 500,000 courses of Paxlovid and 300,000 courses of Lagevrio.

The first two oral treatments for COVID-19 have been approved for use in Australia by the country's medical regulator.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.